Age-dependent dopaminergic dysfunction following fetal exposure to atrazine in SD rats

Environmental Toxicology and Pharmacology

Volumn 37, Issue 3, 2014, Pages

  Li, Yanshu ^a   Sun, Yan ^a   Yang, Junwei ^a   Wu, Yanping ^a   Yu, Jia ^a   Li, Baixiang ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Aging; Atrazine; Neurotoxicity; Parkinson disease

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; AMINE OXIDASE (FLAVIN CONTAINING); ATRAZINE; CATECHOL METHYLTRANSFERASE; DOPAMINE; DOPAMINE TRANSPORTER; HOMOVANILLIC ACID; LEVODOPA; NUCLEAR RECEPTOR RELATED FACTOR 1; TYROSINE 3 MONOOXYGENASE; VESICULAR MONOAMINE TRANSPORTER 2; HERBICIDE; MESSENGER RNA; NR4A2 PROTEIN, RAT; SLC18A2 PROTEIN, RAT; VESICULAR MONOAMINE TRANSPORTER;

AGE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD PLACENTA BARRIER; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE METABOLISM; DOPAMINE UPTAKE; DOPAMINERGIC SYSTEM; FEMALE; FETUS; GENE EXPRESSION; MESENCEPHALON; NEUROTOXICITY; NONHUMAN; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPRAGUE DAWLEY RAT; SUBSTANTIA NIGRA; AGING; ANIMAL; DRUG EFFECTS; FETOMATERNAL TRANSFUSION; GENETICS; METABOLISM; PHYSIOLOGY; PREGNANCY; TOXICITY;

3,4-DIHYDROXYPHENYLACETIC ACID; AGING; ANIMALS; ATRAZINE; CORPUS STRIATUM; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; FETUS; HERBICIDES; HOMOVANILLIC ACID; LEVODOPA; MATERNAL-FETAL EXCHANGE; NUCLEAR RECEPTOR SUBFAMILY 4, GROUP A, MEMBER 2; PREGNANCY; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SUBSTANTIA NIGRA; TYROSINE 3-MONOOXYGENASE; VESICULAR MONOAMINE TRANSPORT PROTEINS;

EID: 84901372127     PISSN: 13826689     EISSN: 18727077     Source Type: Journal    
DOI: 10.1016/j.etap.2014.04.023     Document Type: Article

References (30)

1. Castillo S.O., Baffli J.S., Palkovits M., Goldstein D.S., Kopin I.J., Witta J., Magnuson M.A., Nikodem V.M. Dopamine biosynthesis is selectively abolished in substantia nigra/ventral tegmental area but not in hypothalamic Neurons in mice with targeted disruption of the Nurrl Gene. Mol. Cell. Neurosci. 1998, 11:36-46.
2. Conneely O.M., He Y., Jankovic J., Apel S.H. Reduced Nurr1 expression increase the vulnerability of mesencephalic dopamine neurons to MTPT-induced injury. J. Neurochem. 1999, 73:2218-2221.
3. Coban A., Filipov N.M. Dopaminergic toxicity associated with oral exposure to the herbicide atrazine in juvenile male C57BL/6 mice. J. Neurochem. 2007, 100:1177-1187.
4. Das P.C., McElroy W.K., Cooper R.L. Differential modulation of catecholamines by chlorotriazine herbicides in pheochromocytoma (PC12) cells in vitro. Toxicol. Sci. 2000, 56:324-331.
5. Di Nonte D.A., Lavasani M., Manning-Bog A.B. Environmental factors in Parkinson's disease. Neurotoxicology 2002, 23:487-502.
6. Eldridg J.C., Tennant M.K., Wetzel L.T., Breckenridge C.B., Stevens J.T. Factors affecting mammary tumor incidence in chlorotriazine-treated female rats: hormonal properties, dosage, and animal strain. Environ. Heath Perspect. 1994, 102:29-36.
7. Eldridge J.C., Wetzel L.T., Tyrey L. Estrous cycle patterns of Sprague-Dawley rats during acute and chronic atrazine administration. Reprod. Toxicol. 1999, 13:491-499.
8. Fornai F., Battaglia G., Gesi M., Giorgi F.S., Orzi F., Nicoletti F., Ruggieri S. Time-course and dose-response study on the effects of chronic L-DOPA administration on striatal dopamine levels and dopamine transporter following MPTP toxicity. Brain Res. 2000, 887:110-117.
9. Filipov N.M., Stewart M.A., Carr R.L., Sistrunk S.C. Dopaminergic toxicity of the herbicide atrazine in rat striatal slices. Toxicology 2007, 232:68-78.
10. Guillot T.S., Richardson J.R., Wang M.Z., Li Y.J., Taylor T.N., Ciliax B.J., Zachrisson O., Mercer A., Miller G.W. PACAP38 increases vesicular monoamine transporter 2 (VMAT2) expression and attenuates methamphetamine toxicity. Neuropeptides 2008, 42:423-434.
11. Guzzella L. Herbicide contamination of surficial groundwater in Northern Italy. Environ. Pollut. 2006, 142:344-353.
12. Hossain M.M., Filipov N.M. Alteration of dopamine uptake into rat striatal vesicles and synaptosomes caused by an in vitro exposure to atrazine and some of its metabolites. Toxicology 2008, 248:52-58.
13. Jourdain S., Morissette M., Morin N., Di Paolo T. Oestrogens prevent loss of dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) in Substantia nigra of 1-methyl-4-Phenyl-1,2,3,6-tetrahydropyridine mice. Neuroendocrinology 2005, 17:509-517.
14. Jianga C., Wana X., Hea Y., Pana T., Jankovicb J., Lea W. Age-dependent dopaminergic dysfunction in Nurr1 knockout mice. Exp. Neurol. 2005, 191:154-162.
15. Lu W., Wolf M.E. Expression of dopamine transporter and vesicular monoamine transporter 2 mRNAs in rat midbrain after repeated amphetamine administration. Brain Res. Mol. Brain Res. 1997, 49:137-148.
16. Miller G.W., Gainetdinov R.R., Levey A.I., Caron M.G. Dopamine transporters and neuronal injury. Trends Pharmacol. Sci. 1999, 20:424-429.
17. Miller G.W., Staley J.K., Heilman C.J., Perez J.T., Mash D.C., Rye D.B., Levey A.I. Immunochemical analysis of dopamine transporter protein in Parkinson's disease. Ann. Neurol. 1997, 41:530-539.
18. Miller G., WErickson J.D., Perez J.T., Penland S.N., Mash D.C., Rye D.B., Levey A.I. Immunochemical analysis of vesicular monoamine transporter (VMAT 2) protein in Parkinson's disease. Exp. Neurol. 1999, 156:138-148.
19. Pankratz N., Foroud T. Genetics of Parkinson's disease. NeuroRx 2004, 1(2):235-242.
20. Paske N., Berry B., Schmitz J., Sullivan D. Determination of low-level agricultural residues in soft drinks and sports drinks by liquid chromatography/tandem mass spectrometry: single-laboratory validation. AOAC Int. 2007, 90:521-533.
21. Priyadarshi A., Khuder S.A., Schaub E.A., Shrivastava S. A meta-analysis of Parkinson's disease and exposure to pesticides. Neurotoxicology 2000, 21:435-440.
22. Poienaru S., Sarpe N. The residual effect of imazethapyr applied in soybean to barley and winter wheat in Romania. Commun. Agric. Appl. Biol. Sci. 2006, 71:829-835.
23. Rodriguez V.M., Thiruchelvam M., Cory-Slechta D.A. Sustained exposure to the widely used herbicide atrazine: altered function and loss of neurons in brain monoamine systems. Environ. Health Perspect. 2005, 113:708-715.
24. Saucedo-Cardenas O., Quintana-Hau J.D., Le W.D., Smidt M.P., Cox J.J., Smidt M.P., Asbreuk C.H.J., Cox J.J., Chen H., Johnson R.L., Burbach J.P.H. A second independent pathway for development of mesencephalic dopaminergic neurons requires Lmx1b. Nat. Neurosci. 2000, 3:337-341.
25. Smidt M.P., van Schaick H.A.S., Lanctot Tremblay J.J., Cox J.J., van der Kleij A.A.A., Wolterink G., Drouin J., Burbach J.P.H. A homeodomain gene ptx3 has highly retricted brain expression in mesencephalic dopaminergic neurons. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:13305-13310.
26. Semchuk K.M., Love E.J., Lee R.G. Parkinson's disease and exposure to agricultural work and pesticide chemicals. Neurology 1992, 42:1328-1335.
27. Stoker T.E., Laws S.C., Guidici D.L., Cooper R.L. The effect of atrazine on puberty in male Wistar rats: an evaluation in the protocol for the assessment of pubertal development and thyroid function. Toxicol. Sci. 2000, 58:50-59.
28. Sarasin A., Schlumpf M., Müller M., Fleischmann I., Lauber M.E., Lichtensteiger W. Adrenal-mediated rather than direct effects of nicotine as a basis of altered sex steroid synthesis in fetal and neonatal rat. Reprod. Toxicol. 2003, 17:153-162.
29. Xiao Q., Castino S.O., Nikodem V.M. Distribution of messenger RNAs for the orphan nuclear receptors Nurrl and Nur77(NGFI-B) in adult rat brain adult rat brain using in situ hybridizatiorl. Neuroscience 1996, 75:221-230.
30. Zetterstrom R.H., Willianms R., Perlmann T., Olson L. Cellular expression of the immediate early transcription factor Nurr1 and NGFI-B suggeste a gene regulator role several brain regions including the nigrostriatal dopamine system. Mol. Brain Res. 1996, 41:111-120.